StockData
Tevogen Inc. logo

Tevogen Inc. (TVGNW) bonds

TVGNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGN
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.09+0.01 (+18.24%)

Close on Oct 30, 2026Market cap $38.42MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Tevogen reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

Individual notes, bonds and loans

Tevogen's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.